A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting

A 10-month longitudinal household study of pre-school children and their families was undertaken with monthly visits collecting epidemiological data and nasopharyngeal swabs in Hertfordshire, England from 2001 to 2002. Pneumococcal culture was with standard methods. In total, 121 families (489 indiv...

Full description

Saved in:
Bibliographic Details
Published inEpidemiology and infection Vol. 133; no. 5; pp. 891 - 898
Main Authors HUSSAIN, M., MELEGARO, A., PEBODY, R. G., GEORGE, R., EDMUNDS, W. J., TALUKDAR, R., MARTIN, S. A., EFSTRATIOU, A., MILLER, E.
Format Journal Article
LanguageEnglish
Published Cambridge, UK Cambridge University Press 01.10.2005
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A 10-month longitudinal household study of pre-school children and their families was undertaken with monthly visits collecting epidemiological data and nasopharyngeal swabs in Hertfordshire, England from 2001 to 2002. Pneumococcal culture was with standard methods. In total, 121 families (489 individuals) took part. Mean prevalence of carriage ranged from 52% for age groups 0–2 years, 45% for 3–4 years, 21% for 5–17 years and 8% for [ges ]18 years. Carriage occurred more than once in 86% of children aged 0–2 years compared to 36% of those aged [ges ]18 years. The most prevalent serotypes in the 0–2 years age group were 6B followed by 19F, 23F, 6A and 14. Young children were responsible for the majority of introductions of new serotypes into a household. Erythromycin resistance (alone or in combination) occurred in 10% of samples and penicillin non-susceptibility in 3·7%. Overall the recently licensed 7-valent conjugate vaccine (PCV) would protect against 64% of serotypes with no intra-serogroup cross protection and 82% with such protection. Nasopharyngeal carriage of S. pneumoniae is common in a UK setting in the pre-conjugate vaccine era. PCV would protect against a large proportion of carriage isolates. However, the impact of vaccination on non-vaccine serotypes will need to be monitored.
Bibliography:PII:S0950268805004012
ark:/67375/6GQ-PVN7J38R-R
istex:A31C32BC3BB85BC9C7E811B8D6657C626677AFD5
PMID:16181510
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0950-2688
0014-4797
1469-4409
1469-4441
DOI:10.1017/S0950268805004012